Skip to content
Psych Dictionary

Sleep restriction therapy

(SRT)

  • Method
  • Moderate evidence
  • Published October 19, 2026
  • 10 sources
  • 4 min read

In short

Sleep restriction therapy is a behavioral treatment for chronic insomnia that limits the time allowed in bed to about the time a person actually sleeps, then adjusts that window as sleep efficiency changes. It is a core component of CBT for insomnia and is also delivered on its own.

Key facts

Developed by
Spielman, Saskin and Thorpy, who described it in 1987
Origin
1987 (first published description)
Also known as
Sleep restriction; Restriction of time in bed

State of the evidence

Moderate evidence

As a single treatment, sleep restriction therapy produced moderate-to-large improvements in diary measures of sleep onset, wakefulness after sleep onset and sleep efficiency across four adequate trials[1], and in a pragmatic trial of 642 primary care patients it reduced insomnia severity more than sleep hygiene advice at six months (d = −0.74)[2]. Within CBT for insomnia it is one of the components associated with remission[3]. Protocols vary, objective sleep and daytime functioning are less studied, and daytime sleepiness is common early in treatment[1][4].

Evidence labels summarise the research literature; they are not recommendations. How labels are assigned

Sleep restriction therapy (SRT) is a behavioral treatment for chronic insomnia. An American Academy of Sleep Medicine guideline describes it as a method designed to enhance sleep drive and consolidate sleep by limiting time in bed to the patient’s sleep duration, usually estimated from daily sleep diaries[5]. It is one of the core components of cognitive behavioral therapy for insomnia (CBT-I) and is also delivered as a treatment in its own right.

Spielman’s 1987 description

Spielman, Saskin and Thorpy based the treatment on the recognition that excessive time spent in bed is one of the important factors that perpetuates insomnia. In their report, 35 patients with long-standing insomnia were treated first by marked restriction of the time available for sleep, followed by an extension of time in bed contingent on improved sleep efficiency. After the eight-week program, patients reported more total sleep and improvements in sleep latency, total wake time, sleep efficiency and their own assessment of the insomnia; the improvements remained in the 23 patients followed up a mean of 36 weeks later[6]. The series had no control group. The authors noted that some patients found the restricted schedule difficult to keep[6].

Proposed mechanisms

A 2018 systematic review summarized the four factors through which the treatment was originally thought to work: strengthening homeostatic sleep pressure, stopping the perpetuating practice of spending excessive time in bed, reducing hyperarousal, and tightening the circadian regulation of sleep[7]. The trial protocol for a later primary care study states similar aims, describing the therapy as restricting and standardizing time in bed to increase homeostatic sleep pressure, override cognitive and physiological arousal and strengthen circadian regulation[8].

The mechanistic evidence is thin. The review found 15 studies of generally poor quality, none designed to test whether changes in the proposed mechanisms mediated treatment outcome. Most showed reduced time in bed and shorter sleep onset latency, consistent with increased sleep pressure, but usually measured at the end of treatment, when such changes are outcomes rather than evidence of a mechanism. Reductions in arousal and in night-to-night variability came from a few uncontrolled studies, and no study showed a change in circadian phase. The authors proposed a new model, Triple-R, to be tested prospectively[7].

How protocols set and adjust the window

Published descriptions share a structure rather than fixed values. In the guideline’s summary, time in bed is first limited to the average sleep duration recorded in diaries, then increased or decreased according to sleep efficiency thresholds until sleep duration and overall satisfaction with sleep are sufficient[5]. Spielman’s original protocol likewise made each extension contingent on improved sleep efficiency[6].

How sleep restriction protocols adjust the time-in-bed windowA schematic of protocol structure, not a schedule, with no thresholds or times. At the top, the start: time in bed is limited to the average sleep duration recorded in sleep diaries. An arrow leads into a loop of three steps. Sleep diary, kept daily and used to estimate sleep duration, leads to sleep efficiency, calculated from the diary, which leads to adjusting the time-in-bed window: increased or decreased according to sleep efficiency thresholds. From the adjustment, an arrow returns to the sleep diary. A final arrow leads out of the loop to the end point: repeated until sleep duration and overall satisfaction with sleep are sufficient.PROTOCOL STRUCTURE, NOT A SCHEDULEStartTime in bed limited to the average sleep duration recorded insleep diariesSleep diaryKept daily; used to estimatesleep durationSleep efficiencyCalculated from the diaryAdjust the time-in-bedwindowIncreased or decreasedaccording to sleepefficiency thresholdsUntil sufficientRepeated until sleep duration and overall satisfaction with sleepare sufficient

Figure 1A schematic of how published sleep restriction protocols are structured, not a schedule: time in bed is first limited to the average sleep duration in sleep diaries, then increased or decreased according to sleep efficiency, until sleep and satisfaction with it are sufficient. Protocols differ in their thresholds and timing, so none are shown. After Edinger and colleagues (2021), Spielman, Saskin and Thorpy (1987) and Kyle and colleagues (2020).

Text description

A schematic of protocol structure, not a schedule, with no thresholds or times. At the top, the start: time in bed is limited to the average sleep duration recorded in sleep diaries. An arrow leads into a loop of three steps. Sleep diary, kept daily and used to estimate sleep duration, leads to sleep efficiency, calculated from the diary, which leads to adjusting the time-in-bed window: increased or decreased according to sleep efficiency thresholds. From the adjustment, an arrow returns to the sleep diary. A final arrow leads out of the loop to the end point: repeated until sleep duration and overall satisfaction with sleep are sufficient.

Delivery varies. In the protocol for one primary care trial, practice nurses delivered a manual-based version in four brief weekly sessions totaling about an hour. The first session covered the rationale, a review of sleep diaries, the selection of bed and rise times, and the management of daytime sleepiness, including its implications for driving; participants then kept diaries with sleep efficiency calculation grids so that progress could be reviewed each week[8]. A 2014 review concluded that variability in how the therapy is implemented precludes strong conclusions about its true effect[1].

Evidence as a single treatment

The 2014 systematic review found nine relevant studies, of which four were methodologically adequate. Across them, effects on diary measures of sleep onset latency, wakefulness after sleep onset and sleep efficiency were moderate to large, and the effect on total sleep time was small. The reviewers judged the studies insufficient to evaluate objective sleep and found daytime functioning largely unmeasured[1]. The 2021 guideline gave sleep restriction a conditional recommendation as a single-component therapy, based on low-quality evidence from six studies[5].

A large pragmatic trial followed. In the HABIT trial, 642 adults with insomnia disorder from 35 general practices in England received either four sessions of nurse-delivered sleep restriction therapy plus a sleep hygiene booklet or the booklet alone. At six months, insomnia severity was lower in the sleep restriction group (adjusted mean difference −3.05 points on the Insomnia Severity Index; d = −0.74), the estimated cost per quality-adjusted life year was £2,076, and eight participants in each group had serious adverse events, none judged related to the intervention[2].

Contribution within CBT-I

Within multicomponent CBT-I, a 2024 component network meta-analysis of 241 trials associated sleep restriction with higher remission (incremental odds ratio 1.49) and with improved sleep quality, sleep efficiency and wakefulness after sleep onset[3]. The evidence for CBT-I as a whole is summarized in the entry on that therapy.

Adverse effects and cautions

Early daytime effects are well documented. In a mixed-methods study of 18 patients, every patient reported fatigue or exhaustion after starting treatment, 94% extreme sleepiness, 89% reduced motivation or energy and 72% headache; patients who reported more side effects also tended to report larger improvements in sleep quality[4]. In an uncontrolled laboratory study of 16 patients, objectively measured sleep fell by more than an hour a night during the first weeks and vigilance was impaired, with vigilance and sleepiness back at baseline by three months[9]. A two-week study of 16 adults found no significant change in sleepiness, reaction time or simulated driving, but sleep duration had stayed about the same in that sample, and its authors limited their conclusion to that condition[10].

Guidelines and trials name groups in whom caution is urged. The 2021 guideline notes that the therapy may be contraindicated in people in high-risk occupations such as drivers and heavy machinery operators, in those predisposed to mania or hypomania, and in those with poorly controlled seizure disorders. It adds that some patients, such as older adults or people with chronic pain or depression, may find it hard to fill the extra time out of bed[5]. The HABIT trial excluded, among others, people with epilepsy, schizophrenia or bipolar disorder, other sleep disorders, pregnancy or shift work[8].

Sources10

Numbered in order of first citation.

  1. 1.Miller, C. B., Espie, C. A., Epstein, D. R., Friedman, L., Morin, C. M., Pigeon, W. R., Spielman, A. J., & Kyle, S. D. (2014). The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Medicine Reviews, 18(5), 415–424. https://doi.org/10.1016/j.smrv.2014.01.006
  2. 2.Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L. M., Bower, P., & Aveyard, P. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. The Lancet, 402(10406), 975–987. https://doi.org/10.1016/S0140-6736(23)00683-9
  3. 3.Furukawa, Y., Sakata, M., Yamamoto, R., Nakajima, S., Kikuchi, S., Inoue, M., Ito, M., Noma, H., Takashina, H. N., Funada, S., Ostinelli, E. G., Furukawa, T. A., Efthimiou, O., & Perlis, M. (2024). Components and delivery formats of cognitive behavioral therapy for chronic insomnia in adults: A systematic review and component network meta-analysis. JAMA Psychiatry, 81(4), 357–365. https://doi.org/10.1001/jamapsychiatry.2023.5060
  4. 4.Kyle, S. D., Morgan, K., Spiegelhalder, K., & Espie, C. A. (2011). No pain, no gain: An exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Medicine, 12(8), 735–747. https://doi.org/10.1016/j.sleep.2011.03.016
  5. 5.Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. https://doi.org/10.5664/jcsm.8986
  6. 6.Spielman, A. J., Saskin, P., & Thorpy, M. J. (1987). Treatment of chronic insomnia by restriction of time in bed. Sleep, 45–56. https://doi.org/10.1093/sleep/10.1.45
  7. 7.Maurer, L. F., Espie, C. A., & Kyle, S. D. (2018). How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model. Sleep Medicine Reviews, 42, 127–138. https://doi.org/10.1016/j.smrv.2018.07.005
  8. 8.Kyle, S. D., Madigan, C., Begum, N., Abel, L., Armstrong, S., Aveyard, P., Bower, P., Ogburn, E., Siriwardena, A., Yu, L. M., & Espie, C. A. (2020). Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial). BMJ Open, 10(3), e036248. https://doi.org/10.1136/bmjopen-2019-036248
  9. 9.Kyle, S. D., Miller, C. B., Rogers, Z., Siriwardena, A. N., Macmahon, K. M., & Espie, C. A. (2014). Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: Implications for the clinical management of insomnia disorder. Sleep, 37(2), 229–237. https://doi.org/10.5665/sleep.3386
  10. 10.Whittall, H., Pillion, M., & Gradisar, M. (2018). Daytime sleepiness, driving performance, reaction time and inhibitory control during sleep restriction therapy for Chronic Insomnia Disorder. Sleep Medicine, 45, 44–48. https://doi.org/10.1016/j.sleep.2017.10.007

Further reading

  • Miller, C. B., Espie, C. A., Epstein, D. R., Friedman, L., Morin, C. M., Pigeon, W. R., Spielman, A. J., & Kyle, S. D. (2014). The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Medicine Reviews, 18(5), 415–424. https://doi.org/10.1016/j.smrv.2014.01.006
  • Maurer, L. F., Espie, C. A., & Kyle, S. D. (2018). How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model. Sleep Medicine Reviews, 42, 127–138. https://doi.org/10.1016/j.smrv.2018.07.005
  • Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L. M., Bower, P., & Aveyard, P. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. The Lancet, 402(10406), 975–987. https://doi.org/10.1016/S0140-6736(23)00683-9

Cite this entry

  • APA 7

    Psych Dictionary. (2026, October 19). Sleep restriction therapy (SRT). In Psych Dictionary. https://www.psychdictionary.com/methods/sleep-restriction-therapy

  • MLA 9

    “Sleep Restriction Therapy (SRT).” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/methods/sleep-restriction-therapy.

Written by Editorial team. First published October 19, 2026. Editorial standards

Educational reference material. Nothing on this site is a diagnosis, a treatment recommendation or a substitute for care from a qualified clinician.